No Data
No Data
Accelerating recovery? In March, domestic Innovative Drugs investment and financing increased by about 50% year-on-year, and the Hong Kong Stock pharmaceutical Sector collectively surged.
① In March, domestic investment and financing for Innovative Drugs increased by approximately fifty percent year-on-year, how significant is the Bullish impact? ② The Hong Kong stock market's pharmaceutical Sector rose collectively, which stocks are attracting market attention?
Hong Kong stock morning report | John Lee Ka-chiu engaged in in-depth exchanges with representatives of the "Hangzhou Six Little Dragons" companies. Trump is considering exempting Auto Manufacturers from some tariffs.
① John Lee Ka-chiu had in-depth discussions with representatives from the 'Six Little Dragons of Hangzhou.' ② The Inner Mongolia Ministry of Industry and Information Technology reported that the computing power scale of Inner Mongolia has reached around 0.12 million P, ranking first in the country. ③ USA President Trump is considering exempting Auto Manufacturers from certain tariffs. ④ NIO's Li Bin predicts that China's share of the Global auto industry will exceed 40%.
Asymchem Laboratories: 2025 First Quarter Report
Gelonghui announcement highlights (Hong Kong stocks) | Tianqi Lithium Corporation (09696.HK) expects a net income of 82 million to 0.123 billion yuan in the first quarter.
[Today's Focus] Tianqi Lithium Corporation (09696.HK) expects a net income of 82 million to 0.123 billion yuan in the first quarter. Tianqi Lithium Corporation (09696.HK) announced that it expects that for the three months ending March 31, 2025, (i) the net income attributable to shareholders of the company is expected to be in the range of 82 million yuan to 123 million yuan (unaudited), while in the same period last year, the group recorded a net loss attributable to shareholders of the company of 3,896.78 million yuan; (ii) the net income excluding non-recurring gains and losses is expected to be in the range of 32 million yuan to...
Asymchem Laboratories Releases 2025 First Quarter Financial Report
Asymchem Laboratories (06821) announced the first quarter results with a net profit attributable to the parent company of approximately 0.327 billion yuan, a year-on-year increase of 15.83%.
Asymchem Laboratories (06821) announced its first-quarter performance for 2025, with revenue of approximately 1.541 billion yuan, a year-on-year increase...